Clinical trial · Observational
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
Patients' Preferences for Adjuvant or Neoadjuvant Chemotherapy in Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study is to ask women treated with adjuvant or neoadjuvant chemotherapy for breast cancer what survival benefit would justify the treatment. The benefit should be evaluated in terms of Survival rate trade off and Survival time trade off value. The analyses will be conducted into three different groups of patients to value the survival benefit expected: 1. before to start the chemotherapy 2. during chemotherapy 3. after the end of chemotherapy
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Female Breast Cancer | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Completion of questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Before chemotherapy start
- description
- Women candidate to adjuvant or neoadjuvant chemotherapy for breast cancer at the time of informed consent (interview before the start of CT)
- interventionNames
- Other: Completion of questionnaires
- label
- During chemotherapy
- description
- Women who are receiving chemotherapy at the time of informed consent (interview within 1 year from beginning of CT)
- interventionNames
- Other: Completion of questionnaires
- label
- After chemotherapy end
- description
- Women who already received chemotherapy at the time of informed consent (interview after more than 4 years of CT end)
- interventionNames
- Other: Completion of questionnaires
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with early or locally advanced breast cancer * Patients candidate to adjuvant/neoadjuvant chemotherapy or patients who are receiving adjuvant/neoadjuvant chemotherapy or patients who received adjuvant/neoadjuvant chemotherapy * Sufficient literacy in Italian to complete the questionnaires * Patients must provide signed, written or advanced electronic signature (AES or AdES), informed consent Exclusion Criteria: * None
References
Publications (0)
Data not yet available